Alzheimer's disease (AD)
Showing 26 - 50 of >10,000
Alzheimer's Disease (AD), Dementia, Cognitive Decline Trial in San Antonio (Donepezil)
Not yet recruiting
- Alzheimer's Disease (AD)
- +3 more
-
San Antonio, TexasUniveristy of Texas Health Science Center at San Antonio (UTHSCS
Oct 19, 2022
Healthy Elderly Trial in Leiden (NX210c, Placebo)
Recruiting
- Healthy Elderly
- NX210c
- Placebo
-
Leiden, Zuid-Holland, NetherlandsCentre for Human Drug Research
Apr 12, 2023
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Mild Cognitive Impairment, Alzheimer 1 Trial in Morgantown (Aducanumab, Exablate Model 4000 Type 2)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease 1
- Aducanumab
- Exablate Model 4000 Type 2
-
Morgantown, West VirginiaWest Virginia University Rockefeller Neuroscience Institute
Jul 19, 2022
Dementia, Alzheimer, Infections Trial (TRAIN AD 2.0)
Not yet recruiting
- Dementia
- +2 more
- TRAIN AD 2.0
- (no location specified)
Jul 10, 2023
Alzheimer's Disease Trial in United States (Posiphen, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Posiphen
- Placebo
-
La Jolla, California
- +5 more
Aug 1, 2022
Alzheimer's Dementia With Behavioral Disturbance Trial in Charlestown (Acupuncture needle)
Terminated
- Alzheimer's Dementia With Behavioral Disturbance
- Acupuncture needle
-
Charlestown, MassachusettsClinical Translational Research Unit
Jan 6, 2022
Moderate to Severe Alzheimer's Disease Trial (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)
Not yet recruiting
- Moderate to Severe Alzheimer's Disease
- GV1001 Placebo
- +2 more
- (no location specified)
Mar 28, 2022
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Mild Cognitive Impairment, Alzheimer Trial in Chongqing (Computerized Cognitive Training, Treatment As Usual)
Completed
- Mild Cognitive Impairment
- Alzheimer Disease
- Computerized Cognitive Training
- Treatment As Usual
-
Chongqing, Chongqing, ChinaThe First Affiliated Hospital of Chongqing Medical University
Oct 19, 2023
Alzheimer's Disease, Mild Cognitive Impairment Trial in Australia, United States (Donepezil, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Mild Cognitive Impairment
- Donepezil
- Placebo
-
Long Beach, California
- +9 more
Jan 31, 2023
Mild Cognitive Impairment, Alzheimer Trial in Baltimore (Trier Social Stress Test)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Trier Social Stress Test
-
Baltimore, MarylandJohns Hopkins School of Medicine
Mar 20, 2023
Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside
Recruiting
- Alzheimer Disease
- Dementia
- Placebo
- +2 more
-
Bergen, Vestland, Norway
- +1 more
Nov 25, 2022
Healthy Aging, Alzheimer, Metabolic Disease Trial in Kansas City (Water Immersion Heat Therapy)
Not yet recruiting
- Healthy Aging
- +2 more
- Water Immersion Heat Therapy
-
Kansas City, KansasUniveristy of Kansas Medical Center
Aug 28, 2023
Poor Quality Sleep Trial in Miami (Cognitive Behavioral Therapy (CBT))
Recruiting
- Poor Quality Sleep
- Cognitive Behavioral Therapy (CBT)
-
Miami, FloridaUniversity of Miami
Sep 28, 2022
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Alzheimer Trial in Houston (Choline)
Recruiting
- Alzheimer Disease
-
Houston, TexasThe University of Texas Health Science Center at Houston (UTHeal
May 25, 2023
Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease Trial in Downey (FitMi AD, Conventional exercise
Not yet recruiting
- Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease
- FitMi AD
- Conventional exercise program
-
Downey, CaliforniaRancho Research Institute, Inc
Aug 15, 2022
Neurobehavioral Problems, Alzheimer Trial in Bayamon (IGC-AD1)
Enrolling by invitation
- Neurobehavioral Problems
- Alzheimer Disease
-
Bayamon, Puerto RicoInstituto Sancoop
Sep 14, 2022
Mild to Moderate Alzheimer's Disease Trial (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)
Not yet recruiting
- Mild to Moderate Alzheimer's Disease
- GV1001 Placebo
- +2 more
- (no location specified)
Dec 29, 2021
PrecivityAD2(TM) Clinician Survey
Not yet recruiting
- Alzheimer Disease
- +5 more
- PrecivityAD2(TM) blood test
- (no location specified)
Aug 30, 2023
Gut Microbiome and Blood Indices in AD and Their Spousal
Recruiting
- Alzheimer Disease
- Gut Biome
-
Charlottesville, VirginiaUniversity of Virginia
Jan 18, 2023